Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics

doi:10.1016/j.jamda.2017.12.098

Journal of the American Medical Directors Association

Volume 19, Issue 4, April 2018, Pages 371.e11-371.e17

https://doi.org/10.1016/j.jamda.2017.12.098 Get rights and content

Abstract

Background and objective

Falls are a major public health problem in older adults. Earlier studies showed that psychotropic medication use increases the risk of falls. The aim of this study is to update the current knowledge by providing a comprehensive systematic review and meta-analysis on psychotropic medication use and falls in older adults.

Methods and design

This study is a systematic review and meta-analysis. A search was conducted in Medline, PsycINFO, and Embase. Key search concepts were “falls,” “aged,” “medication,” and “causality.” Studies were included that investigated psychotropics (antipsychotics, antidepressants, anxiolytics, sedatives, and hypnotics) as risk factors for falls in participants ≥60 years of age or participants with a mean age of ≥70 years. Meta-analyses were performed using generic inverse variance method pooling unadjusted and adjusted odds ratio (OR) estimates separately.

Results

In total, 248 studies met the inclusion criteria for qualitative synthesis. Meta-analyses using adjusted data showed the following pooled ORs: antipsychotics 1.54 [95% confidence interval (CI) 1.28–1.85], antidepressants 1.57 (95% Cl 1.43–1.74), tricyclic antidepressants 1.41 (95% CI 1.07–1.86), selective serotonin reuptake inhibitors 2.02 (95% CI 1.85–2.20), benzodiazepines 1.42 (95%, CI 1.22–1.65), long-acting benzodiazepines 1.81 (95%, CI 1.05–3.16), and short-acting benzodiazepines 1.27 (95%, CI 1.04–1.56) Most of the meta-analyses resulted in substantial heterogeneity that did not disappear after stratification for population and healthcare setting.

Conclusions

Antipsychotics, antidepressants, and benzodiazepines are consistently associated with a higher risk of falls. It is unclear whether specific subgroups such as short-acting benzodiazepines and selective serotonin reuptake inhibitors are safer in terms of fall risk. Prescription bias could not be accounted for. Future studies need to address pharmacologic subgroups as fall risk may differ depending on specific medication properties. Precise and uniform classification of target medication (Anatomical Therapeutic Chemical Classification) is essential for valid comparisons between studies.

Section snippets

Identification of Studies

A search was performed in Medline, PsycINFO, and Embase from onset until September 28, 2016. A customized search strategy was conducted for each database with the help of a clinical librarian (J.D.). The search contained the following key search concepts: “fall,” “aged,” “causality,” and “medication.” The key search term medication contained all known fall-risk-increasing drugs (FRIDs).6, 7, 8, 11, 12, 13 Vosviewer was used to identify other possible medication classes to be added to the

Results

The initial search provided 8927 articles after the removal of duplicates. Of these articles, 1156 full texts were assessed, and 248 articles were included in the qualitative synthesis (Figure 1). Supplementary Tables S1-S6 show the characteristics of included studies. One hundred thirty-eight studies were cohort studies, 57 were cross-sectional, 43 were case-control, 7 were randomized controlled trials, and 3 were case-crossover studies. Of the included studies, 101 were set in the community,

Discussion

This systematic review comprehensively included 248 articles in a qualitative synthesis that evaluated the association between psychotropic medication use and the risk of falling in older adults. Seven medication classes (antipsychotics, antidepressants, TCAs, SSRIs, benzodiazepines, short-acting benzodiazepines, long-acting benzodiazepines) were associated with increased risk of falls in meta-analyses of adjusted data. In the qualitative synthesis, we observed inconsistent associations for

Conclusions

This systematic review and meta-analysis indicates consistent associations between use of antipsychotics, antidepressants, and benzodiazepines and an increased risk of falls in older adults. Because of limited data, evaluation of pharmacologic subgroups and chemical substances was limited to qualitative analysis. To contribute better to current findings henceforward, observational studies should use a clear definition of their target medication and use ATC classification. In addition, studies

Acknowledgments

The authors would like to acknowledge the contribution of EUGMS task and finish group fall-risk-increasing drugs. The group consists following members: Hubert Blain (Montpellier University Hospital), Jean Bousquet (Montpellier University Hospital), Gösta Bucht (Umeå University), Maria Angeles Caballero-Mora (Hospital Universitario De Getafe, Madrid),Tischa van der Cammen (Delft University of Technology), Patrik Eklund (Umeå University), Marielle Emmelot-Vonk (University Medical Centrum,

References (119)

D.D. French et al.
Drugs and falls in community-dwelling older people: A national veterans study
Clin Therapeut
(2006)
D.D. French et al.
A multivariate fall risk assessment model for VHA nursing homes using the minimum data set
J Am Med Dir Assoc
(2007)
S.W. Liu et al.
Serious conditions for ED elderly fall patients: A secondary analysis of the Basel Non-Specific Complaints study
Am J Emerg Med
(2016)
A.M. van Strien et al.
Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly
Maturitas
(2013)
J. Olazaran et al.
Psychotropic medications and falls in nursing homes: A cross-sectional study
J Am Med Dir Assoc
(2013)
A. Bonnerup Vind et al.
Who will fall again? Predictors of further falls in one year following an injurious fall
Eur Geriatr Med
(2011)
E.M. Ebly et al.
Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors
J Clin Epidemiol
(1997)
K. Kallin et al.
Predisposing and precipitating factors for falls among older people in residential care
Public Health
(2002)
N. Kerse et al.
Wearing slippers, falls and injury in residential care
Aust N Z J Public Health
(2004)
H. Luukinen et al.
Risk factors for recurrent falls in the elderly in long-term institutional care
Public Health
(1995)

R.J. Mitchell et al.

Obesity and falls in older people: Mediating effects of disease, sedentary behavior, mood, pain and medication use

Arch Gerontol Geriatr

(2015)

M.L. Svensson et al.

Falls in 84- to 85-year-old people living at home

Accid Anal Prev

(1992)

V. Verhoeven et al.

Happy pills in nursing homes in Belgium: A cohort study to determine prescribing patterns and relation to fall risk

J Clin Gerontol Geriatr

(2014)

P. von Heideken Wagert et al.

Falls in very old people: The population-based Umea 85+ study in Sweden

Arch Gerontol Geriatr

(2009)

J. Whitney et al.

Identification of high risk fallers among older people living in residential care facilities: A simple screen based on easily collectable measures

Arch Gerontol Geriatr

(2012)

EuroSafe. Injuries in the European Union, Summary on injury statistics 2012–2014. Amsterdam (The Netherlands): European...

Important facts about falls

N.V. Carroll et al.

The cost of falls among the community-dwelling elderly

J Manag Care Pharm

(2005)

V.S. Stel et al.

Consequences of falling in older men and women and risk factors for health service use and functional decline

Age Ageing

(2003)

K.A. Hartholt et al.

Societal consequences of falls in the older population: Injuries, healthcare costs, and long-term reduced quality of life

J Trauma

(2011)

R.M. Leipzig et al.

Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs

J Am Geriatr Soc

(1999)

J.C. Woolcott et al.

Meta-analysis of the impact of 9 medication classes on falls in elderly persons

Arch Intern Med

(2009)

S. Hartikainen et al.

Medication as a risk factor for falls: Critical systematic review

J Gerontol A Biol Sci Med Sci

(2007)

H. Park et al.

Medications associated with falls in older people: Systematic review of publications from a recent 5-year period

Eur J Clin Pharmacol

(2015)

F. Bloch et al.

Psychotropic drugs and falls in the elderly people: Updated literature review and meta-analysis

J Aging Health

(2011)

R.M. Leipzig et al.

Drugs and falls in older people: A systematic review and meta-analysis: II. Cardiac and analgesic drugs

J Am Geriatr Soc

(1999)

N.D. Boye et al.

Effectiveness of medication withdrawal in older fallers: Results from the Improving Medication Prescribing to reduce Risk Of FALLs (IMPROveFALL) trial

Age Ageing

(2017)

C. Sjoberg et al.

Effects of medication reviews performed by a physician on treatment with fracture-preventing and fall-risk-increasing drugs in older adults with hip fracture–A randomized controlled study

J Am Geriatr Soc

(2013)

N.J. van Eck et al.

Software survey: VOSviewer, a computer program for bibliometric mapping

Scientometrics

(2010)

ATC

S.E. Lamb et al.

Development of a common outcome data set for fall injury prevention trials: The Prevention of Falls Network Europe consensus

J Am Geriatr Soc

(2005)

Kellogg International Work Group (1987). The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly

Dan Med Bull

(1987)

M.E. Tinetti et al.

Risk factors for falls among elderly persons living in the community

N Engl J Med

(1988)

G.A. Wells et al.

The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses

J.P.T. Higgins et al.

The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

BMJ

(2011)

J.P.T. Higgins et al.

Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]

(2011)

H.C. Abreu et al.

Incidence and predicting factors of falls of older inpatients

Revista de Saude Publica

(2015)

M. Askari et al.

Different risk-increasing drugs in recurrent versus single fallers: Are recurrent fallers a distinct population?

Drugs Aging

(2013)

L. Flicker et al.

Serum vitamin D and falls in older women in residential care in Australia

J Am Geriatr Soc

(2003)

E. Horikawa et al.

Risk of falls in Alzheimer's disease: A prospective study

Intern Med

(2005)

S. Iinattiniemi et al.

Falls risk among a very old home-dwelling population

Scand J Prim Health Care

(2009)

A. John de Carle et al.

Risk factors for falling in a psychogeriatric unit

Int J Geriatr Psychiatry

(2001)

K. Kallin et al.

Drugs and falls in older people in geriatric care settings

Aging Clin Exp Res

(2004)

D.K. Kiely et al.

Identifying nursing home residents at risk for falling

J Am Geriatr Soc

(1998)

M. Kron et al.

Risk indicators for falls in institutionalized frail elderly

Am J Epidemiol

(2003)

F. Landi et al.

Psychotropic medications and risk for falls among community-dwelling frail older people: An observational study

J Gerontol Ser A Biol Sci Med Sci

(2005)

P. Mecocci et al.

Cognitive impairment is the major risk factor for development of geriatric syndromes during hospitalization: Results from the GIFA study

Dement Geriatr Cogn Disord

(2005)

U. Moller et al.

Prevalence and predictors of falls and dizziness in people younger and older than 80 years of age-A longitudinal cohort study

Arch Gerontol Geriatr

(2013)

C.A. Mustard et al.

Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents

Am J Epidemiol

(1997)

C.I. Neutel et al.

New evidence on benzodiazepine use and falls: The time factor

Age Ageing

(1996)

Cited by (281)

Preventable or potentially inappropriate psychotropics and adverse health outcomes in older adults: systematic review and meta-analysis
2024, Journal of Nutrition, Health and Aging
To systematically review and quantitatively synthetize evidence on the use of PIPs linked to adverse health outcomes in older adults.
A Medline, Embase® and Opengrey libraries search was conducted from 2004 to February 2021, using the PICO model: older people, psychotropic drugs, inappropriate prescribing, and adverse drug events. Fixed-effects and random-effects meta-analysis were performed from 3 eligible studies using an inverse-variance method.
Of the 1943 originally identified abstracts, 106 met the inclusion criteria and 7 studies were included in this review. All were of good quality. The number of participants ranged from 318 to 383,150 older adults (54.5–74.4% women). Associations were found between PIPs use and decreased personal care activities of daily living (ADL), unplanned hospitalizations, falls and mortality. In the pooled analysis, association with falls was confirmed (1.23 [95%CI: 1.15;1.32]).
Participants of 65 years and older treated with PIPs were more at risk of adverse health outcomes than those using no PIPs, including greater risks of falls, functional disabilities, unplanned hospitalizations, and mortality. Results of the present systematic review and meta-analysis provide additional evidence for an appropriate and safe use of psychotropics in older adults.
Efficacy of deprescribing on health outcomes: An umbrella review of systematic reviews with meta-analysis of randomized controlled trials
2024, Ageing Research Reviews
Deprescribing is an important intervention across different settings in medicine, but the literature supporting such a practice is still conflicting. Therefore, we aimed to capture the breadth of outcomes reported and assess the strength of evidence of the use of deprescribing for health outcomes.
Umbrella review of systematic reviews of the use of deprescribing searching in Medline, Scopus, and Web of Science until 01 November 2023. The grading of evidence was carried out using the GRADE for intervention studies, whilst data regarding systematic reviews were reported as narrative findings.
Among 456 papers, 12 systematic reviews (six with meta-analysis) for a total of 231 RCTs and 44,193 patients were included. In any setting, deprescribing was able to significantly reduce the number of total and of potentially inappropriate medications (PIMs) in older patients (low certainty of evidence) and to reduce the proportion of participants potentially having several or PIMs (moderate certainty of evidence). In community, supported by a high certainty of evidence, deprescribing was not more effective than standard care in decreasing injurious falls, any falls or number of fallers. In nursing home, deprescribing was associated with a significantly lower PIMs than standard care (very low certainty of evidence). In end-of-life situations, deprescribing significantly reduced mortality rate of approximately 41% (high certainty of evidence).
Deprescribing is a promising intervention across different settings and situations, but a notable gap in the literature concerning its effects on substantial outcomes still exists.
Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project
2024, Psychiatry Research Communications
Reports on polypharmacy strategies for patients with schizophrenia and major depressive disorder (MDD) are scarce. The nationwide Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project has been used to train psychiatrists on the guidelines for treatment of schizophrenia and MDD. This study aimed to determine whether the EGUIDE program enabled more appropriate evidence-based treatment of outpatients with schizophrenia and MDD. The types and doses of all psychotropics were analyzed in 174 and 147 patients with schizophrenia and MDD, respectively, in 2018 before the EGUIDE program and in 2019 and 2020 after the program. There were no significant differences in the rate of monopharmacy with antipsychotics for schizophrenia; however, the prescriptions of first-generation antipsychotics, anticholinergics, and benzodiazepines for schizophrenia decreased significantly after the program. There were also no significant differences in antidepressant monopharmacy rates for MDD; however, the prescriptions of benzodiazepines in patients with MDD decreased significantly after the program. Significant positive correlations were found between the number of psychotropic prescriptions and dosage of benzodiazepines. In conclusion, the EGUIDE project has improved the prescribing behavior for outpatients with schizophrenia and depression. Therefore, the guideline training program may be useful for regulating the prescribing behavior among physicians.
Fracture patterns in adult onset type 1 diabetes and associated risk factors – A nationwide cohort study
2024, Bone
This study aimed to determine the hazard ratios (HR) for various fracture sites and identify associated risk factors in a cohort of relatively healthy adult people with newly diagnosed type 1 diabetes (T1D).
The study utilized data from the UK Clinical Practice Research Datalink GOLD (1987–2017). Participants included people aged 20 and above with a T1D diagnosis code (n = 3281) and a new prescription for insulin. Controls without diabetes were matched based on sex, year of birth, and practice. Cox regression analysis was conducted to estimate HRs for any fracture, major osteoporotic fractures (MOFs), and peripheral fractures (lower-arm and lower-leg) in people with T1D compared to controls. Risk factors for T1D were examined and included sex, age, diabetic complications, medication usage, Charlson comorbidity index (CCI), hypoglycemia, previous fractures, falls, and alcohol consumption. Furthermore, T1D was stratified by duration of disease and presence of microvascular complications.
The proportion of any fracture was higher in T1D (10.8 %) than controls (7.3). Fully adjusted HRs for any fracture (HR: 1.43, CI95%: 1.17–1.74), MOFs (HR: 1.46, CI95%: 1.04–2.05), and lower-leg fractures (HR: 1.37, CI95%: 1.01–1.85) were statistically significantly increased in people with T1D compared to controls. The primary risk factor across all fracture sites in T1D was a previous fracture. Additional risk factors at different sites included previous falls (HR: 1.64, CI95%: 1.17–2.31), antidepressant use (HR: 1.34, CI95%: 1.02–1.76), and anxiolytic use (HR: 1.54, CI95%: 1.08–2.29) for any fracture; being female (HR: 1.65, CI95%: 1.14–2.38) for MOFs; the presence of retinopathy (HR: 1.47, CI95%: 1.02–2.11) and previous falls (HR: 2.04, CI95%: 1.16–3.59) for lower-arm and lower-leg fractures, respectively. Lipid-lowering medication use decreased the risk of MOFs (HR: 0.66, CI95%: 0.44–0.99).
Stratification of T1D by disease duration showed that the relative risk of any fracture in T1D did not increase with longer diabetes duration (0–4 years: HR: 1.52, CI95%: 1.23–1.87; 5–9 years: HR: 1.30, CI95%: 0.99–1.71; <10 years: HR: 1.07, CI95%: 0.74–1.55). Similar patterns were observed for other fracture sites. Moreover, the occurrence of microvascular complications in T1D was linked to a heightened risk of fractures in comparison to controls. However, when considering the T1D cohort independently, the association was not statistically significant.
In a cohort of relatively healthy and newly diagnosed people with T1D HRs for any fracture, MOFs, and lower-leg fractures compared to controls were increased. A previous fracture was the most consistent risk factor for a subsequent fracture, whereas retinopathy was the only diabetes related one. We postulate a potential initial fracture risk, succeeded by a subsequent risk reduction, which might potentially increase in later years due to the accumulation of complications and other factors.
Association of polypharmacy with occurrence of loneliness and social isolation among older adults
2024, Archives of Gerontology and Geriatrics
Polypharmacy is increasing. The longitudinal association of polypharmacy and social isolation has not been previously reported. The aim of this study was to explore longitudinal associations of polypharmacy with loneliness and social isolation among older adults.
Participants aged 60 years and above in southern Sweden were invited for participation. A total of 1526 and 2556 participants were included in the separate analyses for loneliness and social isolation. Polypharmacy was defined as taking five or more medications. Associations of polypharmacy with occurrence of loneliness and social isolation were estimated using logistic regression models.
During follow-up, 409 and 414 participants developed loneliness and social isolation, respectively. The odds for loneliness occurrence were higher for participants with polypharmacy compared to participants without polypharmacy (OR, 1.37; 95% CI, 1.05–1.78; P = 0.020). For participants without polypharmacy, the probability of developing loneliness was 0.28 (95% CI, 0.25–0.31), while for those with polypharmacy this probability was 25% higher (0.35; 95% CI, 0.30–0.39). The odds for social isolation occurrence were higher for participants with polypharmacy compared to participants without polypharmacy (OR, 1.29; 95% CI, 1.02–1.64; P = 0.036). For participants without polypharmacy, the probability of developing social isolation was 0.16 (95% CI, 0.14–0.18), while for those with polypharmacy this probability was 18% higher (0.19; 95% CI, 0.17–0.22).
Polypharmacy was associated with loneliness and social isolation occurrence among older adults. Consideration of loneliness and social isolation are warranted when caring for older adults taking multiple medications.
An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs
2023, Neuroscience and Biobehavioral Reviews
Antipsychotic medications are widely prescribed in psychotic illnesses and other mental disorders. Effectiveness is well-established, particularly for reducing symptoms such as delusions and hallucinations, but can be impacted by tolerability. Adverse effects are wide-ranging, and vary between antipsychotics, which is clinically important. This umbrella review aimed to comprehensively summarise the extent and quality of evidence for adverse effects associated with antipsychotic use in people with mental disorders. We included 32 meta-analyses of randomised trials and observational studies. The overall robustness of reported associations was considered in terms of review quality, heterogeneity, excess significance bias, and prediction intervals. Using this approach, endocrine and metabolic, movement-related, and sedation and sleep problems were the clinical domains with strongest evidence. The overall quality of included meta-analyses was low, and individual adverse effects were not typically examined in meta-analyses of both randomised trials and observational study designs. Future reviews should focus on adhering to methodological guidelines, consider the complementary strengths of different study designs, and integrate clinically relevant information on absolute rates and severity of adverse effects.

View all citing articles on Scopus

: This work was supported by the Clementine Brigitta Maria Dalderup fund, Amsterdam University fund. The sponsor played no part in the design, methods, data collection, analysis and preparation of this paper.

: The authors declare no conflicts of interest.

View full text

JAMDA OnlineOriginal StudyFall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics

Abstract

Background and objective

Methods and design

Results

Conclusions

Section snippets

Identification of Studies

Results

Discussion

Conclusions

Acknowledgments

Clin Therapeut

J Am Med Dir Assoc

Am J Emerg Med

Maturitas

J Am Med Dir Assoc

Eur Geriatr Med

J Clin Epidemiol

Public Health

Aust N Z J Public Health

Public Health

Arch Gerontol Geriatr

Accid Anal Prev

J Clin Gerontol Geriatr

Arch Gerontol Geriatr

Arch Gerontol Geriatr

Important facts about falls

The cost of falls among the community-dwelling elderly

J Manag Care Pharm

Consequences of falling in older men and women and risk factors for health service use and functional decline

Age Ageing

Societal consequences of falls in the older population: Injuries, healthcare costs, and long-term reduced quality of life

J Trauma

Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs

J Am Geriatr Soc

Meta-analysis of the impact of 9 medication classes on falls in elderly persons

Arch Intern Med

Medication as a risk factor for falls: Critical systematic review

J Gerontol A Biol Sci Med Sci

Medications associated with falls in older people: Systematic review of publications from a recent 5-year period

Eur J Clin Pharmacol

Psychotropic drugs and falls in the elderly people: Updated literature review and meta-analysis

J Aging Health

Drugs and falls in older people: A systematic review and meta-analysis: II. Cardiac and analgesic drugs

J Am Geriatr Soc

Effectiveness of medication withdrawal in older fallers: Results from the Improving Medication Prescribing to reduce Risk Of FALLs (IMPROveFALL) trial

Age Ageing

Effects of medication reviews performed by a physician on treatment with fracture-preventing and fall-risk-increasing drugs in older adults with hip fracture–A randomized controlled study

J Am Geriatr Soc

Software survey: VOSviewer, a computer program for bibliometric mapping

Scientometrics

ATC

Development of a common outcome data set for fall injury prevention trials: The Prevention of Falls Network Europe consensus

J Am Geriatr Soc

Kellogg International Work Group (1987). The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly

Dan Med Bull

Risk factors for falls among elderly persons living in the community

N Engl J Med

The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses

The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

BMJ

Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]

Incidence and predicting factors of falls of older inpatients

Revista de Saude Publica

Different risk-increasing drugs in recurrent versus single fallers: Are recurrent fallers a distinct population?

Drugs Aging

Serum vitamin D and falls in older women in residential care in Australia

J Am Geriatr Soc

Risk of falls in Alzheimer's disease: A prospective study

Intern Med

Falls risk among a very old home-dwelling population

Scand J Prim Health Care

Risk factors for falling in a psychogeriatric unit

Int J Geriatr Psychiatry

Drugs and falls in older people in geriatric care settings

Aging Clin Exp Res

Identifying nursing home residents at risk for falling

J Am Geriatr Soc

Risk indicators for falls in institutionalized frail elderly

JAMDA Online
Original Study
Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics